SEC Form 4 · accession 0001140361-17-010338

BioRestorative Therapies, Inc. · BRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 1, 2017

Accepted (ET)

Mar 2, 2017 · 5:36 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001505497

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 1, 2017	A	30,000	$3.00	A	36,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant^F1	$4.00	Mar 1, 2017	A	30,000	A	Mar 1, 2017	Mar 1, 2022	Common Stock	30,000	30,000	D
Option^F2	$4.70	holding	—	—	—	—	Jun 27, 2024	Common Stock	15,000	15,000	D
Warrant^F3	$15.00	holding	—	—	—	Aug 1, 2014	Jul 11, 2019	Common Stock	1,400	1,400	D
Warrant^F3	$15.00	holding	—	—	—	Aug 1, 2014	Jul 31, 2019	Common Stock	100	100	D
Option^F4	$4.70	holding	—	—	—	—	Oct 23, 2024	Common Stock	25,000	25,000	D
Option^F5	$4.70	holding	—	—	—	—	Sep 4, 2025	Common Stock	60,000	60,000	D
Option^F6	$3.73	holding	—	—	—	—	Jun 10, 2026	Common Stock	64,000	64,000	D

F1In exchange for accrued director fees.
F2The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016.
F3Owned jointly with wife.
F4The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017.
F5The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
F6The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018.